Vitamin Shoppe Inc. (VSI) Upgraded to Hold at Zacks Investment Research
According to Zacks, “Vitamin Shoppe is a specialty retailer and direct marketer of nutritional products. It primarily sells vitamins, minerals, nutritional supplements, herbs, sports nutrition formulas, homeopathic remedies, green living products and health and beauty aids. Based in North Bergen, New Jersey, the company is recognized as an innovator in providing product information, associate training, and customer education. Information is available to consumers through unprecedented outlets including television, radio, friends, family, health practitioners, and the internet. It offers consumers the opportunity to take charge of their own health and wellness requirements, and supplement where necessary. At each store location, consumers can find a comprehensive Learning Center which offers free access to vital information about key health concerns and products. The Vitamin Shoppe is a strong supporter of health and wellness campaigns including Life Supplemented sponsored by the Council for Responsible Nutrition. “
A number of other analysts also recently issued reports on the company. Jefferies Group reissued a hold rating and issued a $28.00 target price on shares of Vitamin Shoppe in a research report on Monday, September 26th. Barclays PLC assumed coverage on Vitamin Shoppe in a research report on Thursday, September 22nd. They issued an equal weight rating and a $29.00 target price for the company. Finally, Wedbush reissued an outperform rating and issued a $39.00 target price on shares of Vitamin Shoppe in a research report on Wednesday, August 3rd. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the company. Vitamin Shoppe currently has an average rating of Hold and a consensus price target of $32.27.
Shares of Vitamin Shoppe (NYSE:VSI) traded down 0.091% during mid-day trading on Thursday, hitting $27.585. The company had a trading volume of 260,460 shares. The company has a market capitalization of $650.56 million, a PE ratio of 16.160 and a beta of 0.55. Vitamin Shoppe has a one year low of $26.02 and a one year high of $34.41. The company’s 50-day moving average is $27.07 and its 200 day moving average is $29.06.
Vitamin Shoppe (NYSE:VSI) last released its earnings results on Wednesday, August 3rd. The company reported $0.55 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.59 by $0.04. Vitamin Shoppe had a return on equity of 11.53% and a net margin of 3.56%. The firm earned $332.70 million during the quarter, compared to analysts’ expectations of $331.58 million. During the same period in the prior year, the business earned $0.57 earnings per share. The business’s quarterly revenue was up 3.2% compared to the same quarter last year. On average, equities research analysts forecast that Vitamin Shoppe will post $2.18 EPS for the current fiscal year.
Large investors have recently added to or reduced their stakes in the company. Acrospire Investment Management LLC purchased a new stake in shares of Vitamin Shoppe during the second quarter worth $135,000. Mason Street Advisors LLC purchased a new stake in shares of Vitamin Shoppe during the second quarter worth $145,000. BlackRock Inc. raised its stake in shares of Vitamin Shoppe by 241.2% in the second quarter. BlackRock Inc. now owns 6,541 shares of the company’s stock worth $200,000 after buying an additional 4,624 shares during the last quarter. Daiwa Securities Group Inc. raised its stake in shares of Vitamin Shoppe by 932.1% in the second quarter. Daiwa Securities Group Inc. now owns 7,400 shares of the company’s stock worth $226,000 after buying an additional 6,683 shares during the last quarter. Finally, Martingale Asset Management L P purchased a new stake in shares of Vitamin Shoppe during the second quarter worth $242,000.
About Vitamin Shoppe
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, which includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats; direct, which sells its products directly to consumers through the Internet, primarily at www.vitaminshoppe.com, and manufacturing, which provides custom manufacturing and private labeling of vitamin, mineral and supplement (VMS) products.
Receive News & Stock Ratings for Vitamin Shoppe Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc. and related stocks with our FREE daily email newsletter.